X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (6) 6
humans (6) 6
adult (5) 5
index medicus (5) 5
male (5) 5
adolescent (4) 4
aged (4) 4
child (4) 4
immunoglobulins, intravenous - therapeutic use (4) 4
immunology (4) 4
middle aged (4) 4
prospective studies (4) 4
10-percent (3) 3
biomedicine (3) 3
efficacy (3) 3
immunodeficiency (3) 3
immunoglobulin g (3) 3
immunoglobulins (3) 3
immunoglobulins, intravenous - administration & dosage (3) 3
immunologic deficiency syndromes - therapy (3) 3
immunologic factors - therapeutic use (3) 3
infectious diseases (3) 3
internal medicine (3) 3
medical microbiology (3) 3
quality-of-life (3) 3
replacement therapy (3) 3
safety (3) 3
young adult (3) 3
agammaglobulinemia - blood (2) 2
agammaglobulinemia - immunology (2) 2
allergy and immunology (2) 2
article (2) 2
bacterial infections (2) 2
care and treatment (2) 2
children (2) 2
common variable immunodeficiency - blood (2) 2
common variable immunodeficiency - immunology (2) 2
diseases (2) 2
double-blind (2) 2
human intravenous immunoglobulin (2) 2
immunoglobulin g - administration & dosage (2) 2
immunoglobulin g - blood (2) 2
immunoglobulins - administration & dosage (2) 2
immunoglobulins, intravenous - adverse effects (2) 2
immunoglobulins, intravenous - blood (2) 2
immunologic deficiency syndromes - immunology (2) 2
immunologic factors - administration & dosage (2) 2
immunology and allergy (2) 2
infusions (2) 2
injections, subcutaneous (2) 2
intravenous immunoglobulin (2) 2
local tolerability (2) 2
medical research (2) 2
pharmacokinetics (2) 2
primary immunodeficiency (2) 2
proline (2) 2
subcutaneous immunoglobulin (2) 2
treatment outcome (2) 2
5-percent (1) 1
adults (1) 1
agammaglobulinemia - drug therapy (1) 1
agammaglobulinemia - physiopathology (1) 1
agammaglobulinemia - therapy (1) 1
allergic reaction (1) 1
allergy (1) 1
antibodies, neutralizing - analysis (1) 1
antibodies, neutralizing - blood (1) 1
antibodies, viral - administration & dosage (1) 1
antibodies, viral - analysis (1) 1
antibodies, viral - blood (1) 1
antibody deficiency (1) 1
area under curve (1) 1
bacterial infections - prevention & control (1) 1
biological availability (1) 1
biological products (1) 1
blood donors (1) 1
body mass index (1) 1
brazil (1) 1
chemistry (1) 1
child, preschool (1) 1
chronic inflammatory demyelinating polyneuropathy (1) 1
cidp (1) 1
clinical neurology (1) 1
common variable immunodeficiency (1) 1
common variable immunodeficiency - drug therapy (1) 1
common variable immunodeficiency - physiopathology (1) 1
common variable immunodeficiency - therapy (1) 1
complications and side effects (1) 1
confidence intervals (1) 1
diagnosis (1) 1
dose-response relationship, immunologic (1) 1
drug substitution (1) 1
drug-related side effects and adverse reactions (1) 1
duits (1) 1
enzyme-linked immunosorbent assay (1) 1
europe (1) 1
gamma-globulin (1) 1
genetic diseases, x-linked - blood (1) 1
genetic diseases, x-linked - drug therapy (1) 1
genetic diseases, x-linked - immunology (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Transfusion, ISSN 0041-1132, 12/2018, Volume 58, Issue S3, pp. 3065 - 3071
Journal Article
Clinical Immunology, ISSN 1521-6616, 2011, Volume 139, Issue 2, pp. 133 - 141
Journal Article
Journal of Clinical Immunology, ISSN 0271-9142, 9/2010, Volume 30, Issue 5, pp. 734 - 745
Subcutaneous human IgG (SCIG) therapy in primary immunodeficiency (PID) offers sustained IgG levels throughout the dosing cycle and fewer adverse events (AEs)... 
serum IgG trough levels | Medical Microbiology | Biomedicine | Immunology | home infusion therapy | L-proline | Subcutaneous immunoglobulin (SCIG) | primary immunodeficiency | Internal Medicine | Infectious Diseases | local tolerability | PRIMARY ANTIBODY DEFICIENCIES | HUMAN INTRAVENOUS IMMUNOGLOBULIN | IGG | COMMON VARIABLE IMMUNODEFICIENCY | INFUSION | IMMUNOLOGY | REPLACEMENT THERAPY | QUALITY-OF-LIFE | HOME THERAPY | 10-PERCENT | IGIV-C | Common Variable Immunodeficiency - immunology | Agammaglobulinemia - immunology | Prospective Studies | Common Variable Immunodeficiency - drug therapy | Immunoglobulin G - blood | Humans | Middle Aged | Male | Common Variable Immunodeficiency - blood | Agammaglobulinemia - drug therapy | Genetic Diseases, X-Linked - drug therapy | Injections, Subcutaneous | Adult | Female | Protein Stability | Child | Genetic Diseases, X-Linked - physiopathology | Genetic Diseases, X-Linked - blood | Immunologic Factors - administration & dosage | Agammaglobulinemia - physiopathology | Genetic Diseases, X-Linked - immunology | Bacterial Infections - prevention & control | Agammaglobulinemia - blood | Immunoglobulins, Intravenous - therapeutic use | Adolescent | Common Variable Immunodeficiency - physiopathology | Aged | Immunologic Factors - adverse effects | Immunologic Factors - therapeutic use | Complications and side effects | Allergy | Bacterial infections | Immunoglobulin G | Immunodeficiency | Proline | Universities and colleges | Allergic reaction
Journal Article
Molecular Immunology, ISSN 0161-5890, 10/2018, Volume 102, pp. 158 - 158
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Clinical Immunology, ISSN 0271-9142, 10/2011, Volume 31, Issue 5, p. 752
  Subcutaneous IgG treatment for primary immunodeficiencies (PI) is particularly well suited for children because it does not require venous access and is... 
Journal Article
Journal of Clinical Immunology, ISSN 0271-9142, 10/2011, Volume 31, Issue 5, pp. 752 - 761
Subcutaneous IgG treatment for primary immunodeficiencies (PI) is particularly well suited for children because it does not require venous access and is mostly... 
Journal Article
Blood, ISSN 0006-4971, 11/2007, Volume 110, Issue 11, pp. 1307 - 1307
Abstract Background Intravenous immunoglobulin (IVIG) is an accepted treatment for immune thrombocytopenic purpura (ITP). A new liquid 10% human IgG... 
Journal Article
Journal of the Peripheral Nervous System, ISSN 1085-9489, 06/2013, Volume 18, Issue 2, pp. 130 - 140
This prospective, multicenter, single-arm, open-label Phase III study aimed to evaluate the efficacy and safety of Privigen registered (10% liquid human... 
Journal Article
Blood, ISSN 0006-4971, 11/2004, Volume 104, Issue 11, pp. 3943 - 3943
Abstract Introduction Intravenous anti-Rh0(D) immune globulin (anti-D) is used as a platelet enhancing therapy in patients with ITP. The following study was... 
Journal Article
1982, ISBN 320350801X, 341
Book
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.